Activated gut-homing CD8+ T cells for coeliac disease diagnosis on a gluten-free diet

Bibliographic Details
Title: Activated gut-homing CD8+ T cells for coeliac disease diagnosis on a gluten-free diet
Authors: Fernando Fernández-Bañares, Natalia López-Palacios, María Corzo, Beatriz Arau, Mercedes Rubio, Marta Fernández-Prieto, Eva Tristán, Mar Pujals, Sergio Farrais, Saúl Horta, Juana María Hernández, Marta Gomez-Perosanz, Pedro A. Reche, María Esteve, Concepción Núñez
Source: BMC Medicine, Vol 19, Iss 1, Pp 1-10 (2021)
Publisher Information: BMC, 2021.
Publication Year: 2021
Collection: LCC:Medicine
Subject Terms: CD8 T cells, Celiac disease, Gluten challenge, Gluten-free diet, IFN-γ ELISPOT, Flow cytometry, Medicine
More Details: Abstract Background The diagnosis of coeliac disease (CD) in individuals that have started a gluten-free diet (GFD) without an adequate previous diagnostic work-out is a challenge. Several immunological assays such as IFN-γ ELISPOT have been developed to avoid the need of prolonged gluten challenge to induce the intestinal damage. We aimed to evaluate the diagnostic accuracy of activated gut-homing CD8+ and TCRγδ+ T cells in blood after a 3-day gluten challenge and to compare it with the performance of IFN-γ ELISPOT in a HLA-DQ2.5 subsample. Methods A total of 22 CD patients and 48 non-CD subjects, all of them following a GFD, underwent a 3-day 10-g gluten challenge. The percentage of two T cell subsets (CD8+ CD103+ β7hi CD38+/total CD8+ and TCRγδ+ CD103+ β7hi CD38+/total TCRγδ+) in fresh peripheral blood drawn baseline and 6 days after the challenge was determined by flow cytometry. IFN-γ ELISPOT assays were also performed in HLA-DQ2.5 participants. ROC curve analysis was used to assess the diagnostic performance of the CD8+ T cell response and IFN-γ ELISPOT. Results Significant differences between the percentage of the two studied subsets of CD8+ and TCRγδ+ cells at days 0 and 6 were found only when considering CD patients (p < 10−3 vs. non-CD subjects). Measuring activated CD8+ T cells provided accurate CD diagnosis with 95% specificity and 97% sensitivity, offering similar results than IFN-γ ELISPOT. Conclusions The results provide a highly accurate blood test for CD diagnosis in patients on a GFD of easy implementation in daily clinical practice.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1741-7015
Relation: https://doaj.org/toc/1741-7015
DOI: 10.1186/s12916-021-02116-z
Access URL: https://doaj.org/article/45ad4a6b99cb4d7786e8ea95c49ba0e4
Accession Number: edsdoj.45ad4a6b99cb4d7786e8ea95c49ba0e4
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:17417015
DOI:10.1186/s12916-021-02116-z
Published in:BMC Medicine
Language:English